These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 31661117)
1. Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma. Liu S; Deng X; Zhang J Mol Med Rep; 2019 Dec; 20(6):5075-5083. PubMed ID: 31661117 [TBL] [Abstract][Full Text] [Related]
2. miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma. He T; Lu C; Gong W; Ge Z; Li R; Li X; Sun C; Li W; Long Q; Liu Q; Lai Y Front Biosci (Landmark Ed); 2024 May; 29(5):186. PubMed ID: 38812297 [TBL] [Abstract][Full Text] [Related]
3. A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell Carcinoma. Huang G; Li X; Chen Z; Wang J; Zhang C; Chen X; Peng X; Liu K; Zhao L; Lai Y; Ni L Pathol Oncol Res; 2020 Oct; 26(4):2425-2434. PubMed ID: 32556891 [TBL] [Abstract][Full Text] [Related]
4. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma. Liep J; Kilic E; Meyer HA; Busch J; Jung K; Rabien A PLoS One; 2016; 11(6):e0157801. PubMed ID: 27336447 [TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma. Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793 [TBL] [Abstract][Full Text] [Related]
6. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma. Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis. Zhou L; Liu S; Li X; Yin M; Li S; Long H Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867 [TBL] [Abstract][Full Text] [Related]
8. Identification of a four-microRNA panel in serum for screening renal cell carcinoma. Chen X; Li R; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y Pathol Res Pract; 2021 Nov; 227():153625. PubMed ID: 34628264 [TBL] [Abstract][Full Text] [Related]
9. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma. Lou N; Ruan AM; Qiu B; Bao L; Xu YC; Zhao Y; Sun RL; Zhang ST; Xu GH; Ruan HL; Yuan CF; Han WW; Shi HC; Yang HM; Zhang XP Urol Oncol; 2017 Jan; 35(1):36.e7-36.e14. PubMed ID: 27633984 [TBL] [Abstract][Full Text] [Related]
10. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R; Slaby O J Transl Med; 2012 Mar; 10():55. PubMed ID: 22440013 [TBL] [Abstract][Full Text] [Related]
11. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma. Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999 [TBL] [Abstract][Full Text] [Related]
12. Profiling of Serum miRNAs Constructs a Diagnostic 3-miRNA Panel for Clear-Cell Renal Cell Carcinoma. Li X; Wen Z; Li R; Lu C; Chen W; Chen X; Huang G; Ni L; Lai Y; Tao L Clin Genitourin Cancer; 2024 Feb; 22(1):23-32. PubMed ID: 37574436 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468 [TBL] [Abstract][Full Text] [Related]
14. Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma. Petrozza V; Carbone A; Bellissimo T; Porta N; Palleschi G; Pastore AL; Di Carlo A; Della Rocca C; Fazi F Int J Mol Sci; 2015 Dec; 16(12):29219-25. PubMed ID: 26670229 [TBL] [Abstract][Full Text] [Related]
15. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs. Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753 [TBL] [Abstract][Full Text] [Related]
16. Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data. Guan L; Tan J; Li H; Jin X Gene; 2018 Mar; 647():205-212. PubMed ID: 29253611 [TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer. Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526 [TBL] [Abstract][Full Text] [Related]
18. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma. Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286 [TBL] [Abstract][Full Text] [Related]
19. Serum microRNA Expression Profiling: Potential Diagnostic Implications of a Panel of Serum microRNAs for Clear Cell Renal Cell Cancer. Yadav S; Khandelwal M; Seth A; Saini AK; Dogra PN; Sharma A Urology; 2017 Jun; 104():64-69. PubMed ID: 28336290 [TBL] [Abstract][Full Text] [Related]
20. Bioinformatic Analysis and Clinical Case Studies Identify CD276 as a Promising Diagnostic Biomarker for Clear Cell Renal Cell Carcinoma. Zhang Z; Xu J; Song Z; Zhang J; Lin Y; Ouyang J Cancer Control; 2024; 31():10732748241250181. PubMed ID: 38669187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]